Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy
about
Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.Multiparametric MRI and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma.Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3'-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression.Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors.Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach.
P2860
Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Somatostatin receptor subtype ...... ions for targeted radiotherapy
@ast
Somatostatin receptor subtype ...... ions for targeted radiotherapy
@en
type
label
Somatostatin receptor subtype ...... ions for targeted radiotherapy
@ast
Somatostatin receptor subtype ...... ions for targeted radiotherapy
@en
prefLabel
Somatostatin receptor subtype ...... ions for targeted radiotherapy
@ast
Somatostatin receptor subtype ...... ions for targeted radiotherapy
@en
P2093
P2860
P50
P1433
P1476
Somatostatin receptor subtype ...... ions for targeted radiotherapy
@en
P2093
Aida Kiviniemi
Janek Frantzén
Jarkko Johansson
Jukka Kemppainen
Maria Gardberg
Pauliina Luoto
Riitta Parkkola
Sami Suilamo
Tuula Tolvanen
Ville Vuorinen
P2860
P2888
P356
10.1186/S13550-015-0106-2
P577
2015-04-22T00:00:00Z
P5875
P6179
1017923227